{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:25:29Z","timestamp":1767993929745,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T00:00:00Z","timestamp":1452038400000},"content-version":"vor","delay-in-days":370,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jacc.2014.11.002","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T21:34:33Z","timestamp":1420493673000},"page":"39-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Choice of Optimal Anticoagulant to\u00a0Support Primary PCI"],"prefix":"10.1016","volume":"65","author":[{"given":"Sanjay","family":"Kaul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2014.11.002_bib1","series-title":"Requiem for a Nun","author":"Faulkner","year":"1975"},{"key":"10.1016\/j.jacc.2014.11.002_bib2","unstructured":"Dvorsky JS, Rulli K. FDA warning letter for\u00a0Angiomax, April 13, 2012. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/EnforcementActivitiesbyFDA\/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies\/UCM301931.pdf. Accessed October 27,\u00a02014."},{"key":"10.1016\/j.jacc.2014.11.002_bib3","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.11.002_bib4","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.11.002_bib5","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1311096","article-title":"Bivalirudin started during emergency transport for primary PCI","volume":"369","author":"Steg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.11.002_bib6","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","volume":"384","author":"Shahzad","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.11.002_bib7","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/eurheartj\/ehu182","article-title":"Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction","volume":"35","author":"Schulz","year":"2014","journal-title":"Euro Heart J"},{"key":"10.1016\/j.jacc.2014.11.002_bib8","unstructured":"Han Y, BRIGHT Investigators. BRIGHT: a prospective randomized trial of bivalirudin monotherapy versus heparin plus tirofiban in patients with acute myocardial infarction undergoing percutaneous coronary intervention. August 20, 2007, updated September 15, 2014. Available at: http:\/\/www.tctmd.com\/show.aspx?id=126013. Accessed October 27,\u00a02014."},{"key":"10.1016\/j.jacc.2014.11.002_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jacc.2014.10.029","article-title":"Bivalirudin versus Heparin with or without glycoprotein IIb\/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials","volume":"65","author":"Stone","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.11.002_bib10","unstructured":"Public Meeting on Meta-Analyses of Randomized Controlled Clinical Trials for the Evaluation of Risk to Support Regulatory Decisions. White Paper for Meta-analysis Public Meeting. November 25, 2013. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/NewsEvents\/UCM372069.pdf. Accessed October 27,\u00a02014."},{"key":"10.1016\/j.jacc.2014.11.002_bib11","unstructured":"U.S. Food and Drug Administration Modernization Act of 1997, November 21, 1997. Available at: http:\/\/www.fda.gov\/RegulatoryInformation\/Legislation\/FederalFoodDrugandCosmeticActFDCAct\/SignificantAmendmentstotheFDCAct\/FDAMA\/FullTextofFDAMAlaw\/default.htm - SEC. 115. Accessed October 27,\u00a02014."},{"key":"10.1016\/j.jacc.2014.11.002_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jama.289.7.853","article-title":"Bivalirudin and provisional glycoprotein IIb\/llla blockade compared with heparin and planned glycoprotein IIb\/llla blockade during percutaneous coronary intervention: REPLACE-2 randomized trial","volume":"289","author":"Lincoff","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.11.002_bib13","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.11.002_bib14","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/jama.293.14.1759","article-title":"Abciximab as adjunctive therapy to reperfusion in acute ST- segment elevation myocardial infarction: a meta-analysis of randomized trials","volume":"293","author":"De Luca","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2014.11.002_bib15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jacc.2004.07.002","volume":"44","author":"Antman","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.11.002_bib16","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/S0140-6736(14)61041-2","article-title":"Is the heat on HEAT-PPCI appropriate?","volume":"384","author":"Berger","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.11.002_bib17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0140-6736(14)61333-7","article-title":"Heparin monotherapy for percutaneous coronary intervention?","volume":"384","author":"Lincoff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.11.002_bib18","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Euro Heart J"},{"key":"10.1016\/j.jacc.2014.11.002_bib19","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial","volume":"377","author":"Stone","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.11.002_bib20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.7326\/0003-4819-130-12-199906150-00019","article-title":"Towards evidence-based medical statistics. 2: the Bayes factor","volume":"130","author":"Goodman","year":"1999","journal-title":"Am Soc Int Med"},{"key":"10.1016\/j.jacc.2014.11.002_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2013.09.027","article-title":"Reduction in cardiac mortality with bivalirudin in\u00a0patients with and without major bleeding: The\u00a0HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction)","volume":"63","author":"Stone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714068636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714068636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T13:56:00Z","timestamp":1537970160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109714068636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0735109714068636"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2014.11.002","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Choice of Optimal Anticoagulant to\u00a0Support Primary PCI","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2014.10.029","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}